Physician profile
Nathan S Dotson
NPI 1194061291
$758.73
in general payments reported to CMS, 2019-2025
9 companies · $210 in 2025
The $210 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $96.24 · 2023: $294 · 2024: $158 · 2025: $210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $662.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $662.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $433.77 | 2022-2025 | Oasis, Grafix, Grafix Pl |
| Kerecis Limited | $121.32 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Abbvie INC. | $45.42 | 2024-2025 | |
| Solventum Corporation | $37.25 | 2024 | Activ.A.C., V.A.C. Veraflo |
| Paratek Pharmaceuticals, INC. | $34.03 | 2025 | Nuzyra |
| Tactile Systems Technology INC | $24.98 | 2025 | Flexitouch Plus, Nimbl |
| Organogenesis INC. | $23.51 | 2022 | |
| Ets Wound Care LLC | $19.23 | 2025 | Mirragen Advanced Wound Matrix |
| Convatec INC. | $19.22 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Dotson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.